158 related articles for article (PubMed ID: 8679358)
21. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation.
Eide PK; Stubhaug A; Stenehjem AE
Neurosurgery; 1995 Dec; 37(6):1080-7. PubMed ID: 8584148
[TBL] [Abstract][Full Text] [Related]
22. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study.
Arendt-Nielsen L; Petersen-Felix S; Fischer M; Bak P; Bjerring P; Zbinden AM
Anesth Analg; 1995 Jul; 81(1):63-8. PubMed ID: 7598284
[TBL] [Abstract][Full Text] [Related]
23. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
Edwards SR; Mather LE; Smith MT
Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
[TBL] [Abstract][Full Text] [Related]
24. Effect of pre- or post-traumatically applied i.v. lidocaine on primary and secondary hyperalgesia after experimental heat trauma in humans.
Holthusen H; Irsfeld S; Lipfert P
Pain; 2000 Dec; 88(3):295-302. PubMed ID: 11068117
[TBL] [Abstract][Full Text] [Related]
25. Peripheral analgesic effects of ketamine in acute inflammatory pain.
Pedersen JL; Galle TS; Kehlet H
Anesthesiology; 1998 Jul; 89(1):58-66. PubMed ID: 9667294
[TBL] [Abstract][Full Text] [Related]
26. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
[TBL] [Abstract][Full Text] [Related]
27. A new method to evaluate central sensitization to pain following surgery. Effect of ketamine.
Stubhaug A
Acta Anaesthesiol Scand Suppl; 1997; 110():154-5. PubMed ID: 9248571
[No Abstract] [Full Text] [Related]
28. Analgesic efficacy of low-dose ketamine. Somatosensory-evoked responses in relation to subjective pain ratings.
Kochs E; Scharein E; Möllenberg O; Bromm B; Schulte am Esch J
Anesthesiology; 1996 Aug; 85(2):304-14. PubMed ID: 8712446
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers.
Schulte H; Graven-Nielsen T; Sollevi A; Jansson Y; Arendt-Nielsen L; Segerdahl M
Acta Anaesthesiol Scand; 2003 Sep; 47(8):1020-30. PubMed ID: 12904196
[TBL] [Abstract][Full Text] [Related]
30. Effects of ketamine on acute somatic nociception in wild-type and N-methyl-D-aspartate (NMDA) receptor epsilon1 subunit knockout mice.
Petrenko AB; Yamakura T; Askalany AR; Kohno T; Sakimura K; Baba H
Neuropharmacology; 2006 May; 50(6):741-7. PubMed ID: 16427663
[TBL] [Abstract][Full Text] [Related]
31. Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain.
Arendt-Nielsen L; Nielsen J; Petersen-Felix S; Schnider TW; Zbinden AM
Br J Anaesth; 1996 Nov; 77(5):625-31. PubMed ID: 8957979
[TBL] [Abstract][Full Text] [Related]
32. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine.
Koppert W; Dern SK; Sittl R; Albrecht S; Schüttler J; Schmelz M
Anesthesiology; 2001 Aug; 95(2):395-402. PubMed ID: 11506112
[TBL] [Abstract][Full Text] [Related]
33. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo.
Eide PK; Jørum E; Stubhaug A; Bremnes J; Breivik H
Pain; 1994 Sep; 58(3):347-354. PubMed ID: 7838584
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.
Hughes AM; Rhodes J; Fisher G; Sellers M; Growcott JW
Br J Clin Pharmacol; 2002 Jun; 53(6):604-12. PubMed ID: 12047485
[TBL] [Abstract][Full Text] [Related]
35. Effects of Different Anesthetics on Pain Processing in an Experimental Human Pain Model.
Nickel FT; Ott S; Möhringer S; Münster T; Rieß S; Filitz J; Koppert W; Maihöfner C
Pain Pract; 2016 Sep; 16(7):820-30. PubMed ID: 26179561
[TBL] [Abstract][Full Text] [Related]
36. Chronic Opioid Therapy Modifies QST Changes After Ketamine Infusion in Chronic Pain Patients.
Maher DP; Zhang Y; Ahmed S; Doshi T; Malarick C; Stabach K; Mao J; Chen L
J Pain; 2017 Dec; 18(12):1468-1475. PubMed ID: 28802882
[TBL] [Abstract][Full Text] [Related]
37. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.
Neri CM; Pestieau SR; Darbari DS
Paediatr Anaesth; 2013 Aug; 23(8):684-9. PubMed ID: 23565738
[TBL] [Abstract][Full Text] [Related]
38. Effect of naloxone on primary and secondary hyperalgesia induced by the human burn injury model.
Brennum J; Kaiser F; Dahl JB
Acta Anaesthesiol Scand; 2001 Sep; 45(8):954-60. PubMed ID: 11576045
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological Arguments Against the Use of Ketamine in Nonmedical Settings.
Green DJ; Masters JC;
J Clin Pharmacol; 2022 Jan; 62(1):7-9. PubMed ID: 34643961
[No Abstract] [Full Text] [Related]
40. Functional interaction between N-methyl-D-aspartate receptor and ascorbic acid during neuropathic pain induced by chronic constriction injury of the sciatic nerve.
Saffarpour S; Nasirinezhad F
J Basic Clin Physiol Pharmacol; 2017 Nov; 28(6):601-608. PubMed ID: 28902622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
